Narayana Health City in Bengaluru concluded a major HLA Testing Camp for thalassemia patients in Eastern India. Organized ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...
Press Trust of India on MSN
Narayana Health Successfully Conducts One of Eastern India's Largest HLA Testing Camps for Children with Thalassemia in Kolkata
Narayana Health City, Bengaluru, yesterday announced the successful completion of one of Eastern India's largest HLA Testing ...
Prof Nicholas Schwab and his colleagues found a biomarker which allows to tell in advance if therapy with glatirameracetate will be efficient in an individual MS patent. Treatment with interferon or ...
Greenwich LifeSciences reports preliminary HLA data from Phase III trial FLAMINGO-01 evaluating GLSI-100 for preventing breast cancer recurrences. Greenwich LifeSciences, Inc. provided an update on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback